Foletta Mark G's Form 4 filing
Dexcom Inc (DXCM) · filed Jun 17, 2026
- Accession no.
- 0001093557-26-000130
- Filed
- Jun 17, 2026
- Trade date
- Jun 15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $296.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Foletta Mark GCIK 0001236389 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | SSaleDisposed | −3,801 | $74.10 | −$281,654.1 | 53,051 | Indirect | |
| Jun 15, 2026 | Common Stock | SSaleDisposed | −199 | $74.82 | −$14,889.18 | 52,852 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.